FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hopfer, U.
Right arrow Articles by Olsen, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hopfer, U.
Right arrow Articles by Olsen, B. R.
(The FASEB Journal. 2005;19:1232-1244.)
© 2005 FASEB

Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye

Ulrike Hopfer1, Naomi Fukai, Helmut Hopfer*, Gunter Wolf{dagger}, Nancy Joyce{ddagger}, En Li§,2 and Bjorn R. Olsen3

Department of Oral and Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts, USA;
* Departments of Pathology and
{dagger} Medicine, University of Hamburg, Hamburg, Germany;
{ddagger} Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA; and
§ Cardiovascular Research Division of Massachusetts General Hospital, Boston, Massachusetts, USA

3Correspondence: Department of Oral and Developmental Biology, Harvard School of Dental Medicine, 188 Longwood Ave., Boston, MA 02115, USA. E-mail: bjorn_olsen{at}hms.harvard.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Collagen VIII is localized in subendothelial and subepithelial extracellular matrices. It is a major component of Descemet’s membrane, a thick basement membrane under the corneal endothelium, where it forms a hexagonal lattice structure; a similar structure, albeit less extensive, may be formed in other basement membranes. We have examined the function of collagen VIII in mice by targeted inactivation of the genes encoding the two polypeptide subunits, Col8a1 and Col8a2. Analysis of these mice reveals no major structural defects in most organs, but demonstrates that type VIII collagen is required for normal anterior eye development, particularly the formation of a corneal stroma with the appropriate number of fibroblastic cell layers and Descemet’s membrane of appropriate thickness. Complete lack of type VIII collagen leads to dysgenesis of the anterior segment of the eye: a globoid, keratoglobus-like protrusion of the anterior chamber with a thin corneal stroma. Descemet’s membrane is markedly thinned. The corneal endothelial cells are enlarged and reduced in number, and show a decreased ability to proliferate in response to different growth factors in vitro. An important function of collagen VIII may therefore be to generate a peri- or subcellular matrix environment that permits or stimulates cell proliferation.—Hopfer, U., Fukai, N., Hopfer, H., Wolf, G., Joyce, N., Li, E., Olsen, B. R. Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye.


Key Words: type VIII collagen • corneal endothelial cells • proliferation


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
TYPE VIII COLLAGEN, a product of some mesenchymal cells as well as many endothelial and epithelial cells, is largely localized in subepithelial or subendothelial matrices (1 2 3 4) . As a member of the short-chain collagen family, collagen VIII molecules are characterized by a short triple-helical domain flanked by a shorter N-terminal nontriple helical NC2 domain and a longer C-terminal nontriple helical NC1 domain (5 , 6) . Two distinct polypeptides, {alpha}1(VIII) and {alpha}2(VIII), have been identified. The two polypeptides show homology to each other and to the {alpha}1 chain of type X collagen (7 8 9) ; recent evidence suggests they form two types of homotrimeric molecules in tissues (10 , 11) . Type VIII collagen is a component of basement membrane-associated matrices in most organs. However, its most prominent location is in Descemet’s membrane (DM), a thick basement membrane of the corneal endothelium, in which collagen VIII molecules ({alpha}1(VIII) and {alpha}2(VIII) homotrimers) are major constituents and assemble into a characteristic hexagonal lattice structure (12) . This lattice structure forms a highly ordered array in a region called the anterior banded zone (ABZ) (13 , 14) . The ABZ is first secreted in utero by the endothelial cells and DM consists entirely of this embryonic banded portion at birth (15) .

Type VIII collagen has been proposed to play a structural role in DM by creating a matrix underneath the endothelial cells that can resist compression while maintaining an open porous structure (6) . Although this collagen has been well characterized structurally, its functional importance is still unclear. In humans, mutations in the {alpha}2(VIII) gene result in corneal endothelial dystrophies, namely, Fuchs’ endothelial dystrophy (FECD) and posterior polymorphous corneal dystrophy (PPCD) (16) . In Fuchs’ dystrophy, DM is markedly thickened by additional abnormal layers posterior to the normal banded layer and the presence of wart-like excrescences. PPCD can be associated with vesicular-like lesions, localized or diffuse thickenings of DM and focal replacement of normally amitotic endothelial cells by abnormally proliferating cells (16 , 17) .

To obtain better insight into the precise role of collagen VIII in organ development, we have generated mice deficient in {alpha}1(VIII) and {alpha}2(VIII) collagen chains. We report here that mice lacking type VIII collagen appear to develop normally and have a normal life span. They exhibit no histological abnormalities in most organs. However, Col8a1–/–/Col8a2–/– null mice develop a distinct phenotype of dysgenesis of the anterior segment of the eye with a globoid, keratoglobus-like protrusion of the anterior chamber. The corneal stroma is diffusely thin, similar to what is seen in human keratoglobus. Descemet’s membrane is markedly thinned and lacks the anterior banded zone. The corneal endothelial cells are enlarged and reduced in number. Finally, mutant corneal endothelial cells show a decreased ability to proliferate in response to different growth factors in vitro, suggesting that collagen VIII may function as an enhancer of growth factor-induced proliferation of cells.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
All experiments were performed in compliance with the regulations of the HMS Standing Committee on Animals.

Construction of the targeting vectors
Col8a1 targeting vector
A murine 129/Sv lambda genomic library (Stratagene, La Jolla, CA, USA) was screened using a Col8a1 cDNA as a probe. A clone of 17 kb was isolated, restriction mapped, and partially sequenced. An 11 kb EcoRI/SalI fragment was subcloned into pBluescript. This fragment spans the whole coding region of the Col8a1 gene. A positive selectable cassette was introduced at the BamHI site to create the replacement vector pUB8a1KO. This cassette contains stop codons in all three frames, an internal ribosomal entry site (IRES), followed by the EGFP gene with an SV40 polyadenylation signal and a neomycin phosphotransferase gene (NEOr) with polyadenylation signal, under control of the mouse PGK promoter. The cassette was generated as follows: the EGFP/poly A gene was amplified by PCR using plasmid pEGFP-N1 (Clontech, Palo Alto, CA, USA) as a template (sense primer: 5'-ACTATGGTGAGCAAGGGCGA-3'; antisense primer: 5'-AATTTACGCCTTAAGATACAT-3'), blunted, ligated downstream of an internal ribosomal entry site. A PGK/NEO/polyA gene was blunted and ligated downstream of the EGFP gene. Finally, BamHI sites were introduced at both ends of the cassette using synthetic BamHI linker (Biolabs, Beverly, MA, USA). The structure of the construct was confirmed by sequencing.

Col8a2 targeting vector
Col8a2 genomic clones were isolated by screening the 129/Sv lambda library with a Col8a2 cDNA clone. One 10 kb clone, which spans both coding exons, was subcloned into pBlueskript (pNFm129-28) and characterized by restriction enzyme mapping and sequencing. A 1.3 kb SacI/KpnI fragment was subcloned to generate plasmid pNFm129-24. A positive selectable cassette containing the neomycin phosphotransferase gene (NEOr) with polyadenylation signal, under the control of a mouse PGK promoter, was introduced into a unique restriction site PflMI in exon 2. pNFm129-24 was then religated into vector pNFm129-28. Finally, the herpes simplex virus thymidine kinase gene, with polyadenylation signal and controlled by a PGK promoter, was cloned in the antisense direction of the NEOr gene for negative selection.

Transfection of ES cells, screening for homologous recombination, and genotyping
Col8a1
To obtain Col8a1 chimeric mice, 50 µg of the Col8a1KO construct was first linearized with EcoRI, electroporated into J1 embryonic stem cells, and selected for resistance with G418 as described (18) . 198 G418-resistant ES cell clones were analyzed for homologous recombination by long template PCR choosing the sense primer inside the NEOr gene (NEO-FOR: 5'-CAGCGCATCGCCTTCTATCGC-3') and the antisense primer outside of the construct (LTa1-REV: 5'-ACAGCTACTAAGACAGGTGCAGAC-3') to amplify a 2 kb fragment. For further analysis, DNA of positive clones were digested with Bgl II, separated on a 0.8% agarose gel, and transferred to a nylon membrane (Hybond N+; Amersham Pharmacia Biotech, Piscataway, NJ, USA). Two probes, a 1.4 kb Sac I/EcoRV fragment chosen from a region downstream of the construct (external probe) and a 600 bp XhoI/Not I fragment inside the EGFP gene (internal probe), were labeled with 32P dCTP by random primer extension using the High Prime Labeling KIT (Roche, Mannheim, Germany). Of 198 G418-resistant embryonic stem cell clones analyzed, two contained the correct targeting event. Both independent clones were injected into C57BL/6J blastocysts to obtain chimeric mice. Male chimeras were mated to C57BL/6J mice and offspring screened for transmission of the disrupted allele. Genomic DNA was obtained from tail biopsies by digestion with proteinase K (19) and screening performed by Southern blots. Further genotyping was performed by PCR to detect the mutated (sense primer 8A1-KO-FOR: 5'-GTGGGGGTGGGGTGGGATTAGATA-3'; antisense primer 8A1-KO-REV: 5'-CTCGGCCCAAGAACCCCAGGAAC-3') and the wild-type alleles (sense primer 8A1-FOR: 5'-CGGGAGTAGGAAAACCAGGAGTGA-3'; antisense primer 8A1-REV: 5'-GGCCCAAGAACCCCAGGAACA-3'). The mice were backcrossed for 8–10 generations into C57BL/6J mice.

Col8a2
To obtain Col8a2 chimeric mice, 50 µg of the construct was linearized, electroporated into J1 embryonic stem cells, and selected for resistance to G418. ES clones were screened using Kpn I digested DNA for Southern blot with an XbaI/PstI probe or by Long Template PCR using sense primer (sense primer f-8KO: 5'TGCATACTCATATTAGCACTGCCTGATACTAGC-3') upstream of the vector and an anti-sense primer (Neo1 : 5'-GCTGCTAAAGCGCATGCTCCAGACTGCCTT-3') within the NEO cassette. Nine of 218 ES clones showed evidence of homologous recombination; of these, four showed homologous recombination without random integration. One clone was injected into C57BL/6 blastocysts and four male chimeras were obtained and mated to C57BL/6J females. Further genotyping was performed by PCR to detect the mutated (sense primer NF-7: 5'-CCGGTAAAGTATGTGCAGC-3'; antisense primer f-NEO: 5'-CAGCGCATCGCCTTCTATCGC-3') and the wild-type alleles (sense primer NF-7: 5'-CCGGTAAAGTATGTGCAGC-3'; antisense primer NF-10: 5'-ATCCTGGGAACATTGCAGG-3'). The mice were backcrossed for at least 12 generations into C57BL/6J mice. Col8a1–/–/Col8a2–/– mice were generated by mating Col8a1 with Col8a2 knockout mice.

Northern blot analyses
Total RNA was extracted from heads of newborn mice with TRI reagent (Sigma, St. Louis, MO, USA). 20 µg of RNA was separated on a 1% agarose gel using a glyoxal-based system (Ambion, Austin, TX, USA) and blotted by downward capillary transfer on a nylon filter. Hybridization was performed at 42°C using a DNA probe containing a 1.2 kb BamHI/EcoRV fragment of 3'UTR of the Col8a1 gene and a 0.5 kb EcoRV/SpeI fragment of 3'UTR of the Col8a2 gene. The ß-actin probe was amplified as a 540 bp PCR-product with intron flanking primers (sense: 5'-GTGGGCCGCTCTAGGCACCAA-3'; antisense: 5'-CTCTTTGATGTCACGCACGATTTC-3'; Clontech).

Histology and immunohistochemistry
All major internal organs (brain, lung, liver, heart, kidney, three different parts of the stomach, duodenum, jejunum, ileum, colon, spleen, testes, ovary), skeletal muscle, aorta, bladder, trachea, skin, thymus, pancreas, salivary glands, and all major joints were dissected from 6-wk, 4-month, 6-month, 1- and 2-year-old mice and fixed overnight in 4% paraformaldehyde in phosphate-buffered saline (PBS) or Bouins fixative. Tissues were dehydrated, embedded in paraffin, and sections 5 µm in thickness were stained with hematoxylin and eosin (H&E) and observed in a light microscope. Kidney sections were stained with periodic acid-Schiff reagent (PAS). Whole eyes were fixed in 10% neutral buffered formalin, dehydrated, then infiltrated and embedded in Historesin (Leica, Heidelberg, Germany) or paraffin. Sections (3 µm) were cut and stained with H&E or PAS. Pictures were taken with an Axioscope microscope (Zeiss, Oberkochen, Germany) and the depth of the anterior chamber was measured by the computer program Axiovision 3.1.

For immunohistochemistry, corneas of adult mice and heads of embryos were fixed in 4% buffered PFA, infiltrated with 20% sucrose and frozen in OCT. Sections of wild-type and Col8a1–/–/Col8a2–/– eyes 5 µm thick were rehydrated, treated with proteinase XXIV (Sigma), blocked in 5% goat serum in PBS, and incubated for 1 h at 37°C with rabbit anti-EGFP antibodies at a dilution of 1:500 (Molecular Probes, Eugene, OR, USA). A nonimmune rabbit serum was used as a control. Fluorescein-anti-rabbit IgG was applied as secondary antibody (DAKO, Glostrup, Denmark). Pictures were taken at various magnifications with an Axioscope fluorescence microscope (Zeiss).

Electron microscopy
Mice at the age of 2 to 6 months were killed and the cornea of four wild-type, four Col8a1–/–/Col8a2–/–, three Col8a1–/–, three Col8a2–/–, and two Col8a1+/–/Col8a2+/– mice were dissected and fixed at room temperature for 2 h in 1.25% formaldehyde, 2.5% glutaraldehyde, and 0.03% picric acid in 0.1M cacodylate buffer pH 7.4. After postfixation with 1% osmiumtetroxide and 1.5% potassiumferrocyanide for 1 h in the dark, specimens were stained en bloc in 1% uranyl acetate for 30 min, dehydrated, and embedded in Epon/Araldite (Embed 812: Electron Microscopy Sciences, Fort Washington, PA, USA). Ultrathin sections were contrasted with uranyl acetate and lead citrate. Pictures were taken in an JEOL 1200EX electron microscope.

Cell culture and characterization of corneal endothelial cells
Mouse corneal endothelial cells (mCECs) were released from isolated Descemet’s membrane using a modification of a published method (2) . In brief, corneas of four wild-type and four knockout mice (backcrossed for eight generations to C57Bl/6 with their second grade control littermates) were dissected and washed in 1x Antibiotic/Antimycotic (Sigma) in HBSS. Descemet’s membrane with endothelium was peeled off and digested in 0.2% dispase II (Roche) and 0.2% bacterial collagenase (Sigma) in HBSS for 30 min at 37°C. Cells were maintained on gelatin-coated plates in DMEM, 10% serum and 1% glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin (Irvine Scientific, Santa Ana, CA, USA) at 37°C and 5% CO2. For cell characterization, cells were grown on glass coverslips and fixed with methanol for 10 min on ice for immunostaining or with 10% formalin for hematoxylin staining. Immunostaining was performed at room temperature using the mouse monoclonal anti-Collagen VIII antibody 8C (Seikagaku, Tokyo, Japan) with an isotype-matched control mouse IgG1 (DAKO) and rabbit anti-EGFP antibodies (Molecular Probes) with nonimmune rabbit IgG as a control. Secondary antibodies were fluorescein-anti-mouse IgG and fluorescein-anti-rabbit IgG (DAKO). Pictures were taken at 20x magnification with an Axioscope fluorescence microscope (Zeiss). RT-PCRs of Col8a1, keratin 14, decorin, and GAPDH on RNA of corneal endothelial cells and renal tubular epithelial cells as non-ocular epithelial control cells were performed as described before (20) .

Proliferation assays
mCECs of passages 2–6 (3x103 cells/well) were plated on gelatin-coated 96-well plates and maintained in DMEM medium supplemented with 10% FCS for 24 h to allow cell attachment. Medium containing 0.1% serum was added for 24 h to synchronize the cells in G0 phase. DNA synthesis was measured by [3H]thymidine incorporation: 2 µCi/mL [3H]thymidine was added for 16 h in the presence of either 10% FCS, 25 ng/mL EGF, 25 ng/mL NGF, 25 ng/mL bFGF, or 0.1% FCS (unstimulated control). Concentrations of growth factors were as published (21 22 23) . At the end of the incubation period, cells were washed twice with PBS and trypsinized. The cell suspensions were subsequently harvested onto a filter paper using an automated cell harvester (Dynatech Labs., Chantilly, VA, USA) before [3H]thymidine incorporation was measured in a ß-scintillation counter. Results were plotted as means of 12 different values. Experiments were repeated three times with two different cell preparations. Statistical significance between individual groups was tested using the nonparametric unpaired Mann-Whitney U test. A P value of <0.05 was considered significant.

Attachment assays
Attachment assays were performed by coating 96-well tissue culture plates with gelatin for 1 h. Corneal endothelial cells were suspended in serum-free DMEM containing 1 mg/mL BSA and plated at a density of 6000 cells/well. Nonadherent cells were rinsed off with PBS after 24 h, and the attached cells were fixed with 10% formalin, washed, and stained with hematoxylin. After washing the cells three times with PBS, the absorbance at 630 nm was measured in a microplate reader (Dynatech Labs.). Means represent the OD at 630 nm of 24 different values. The experiment was repeated three times with two independent cell preparations.

Whole mount staining of mouse corneas
Col8a1–/–/Col8a2–/– mice at the age of 4 to 8 months of both mouse lines (derived from the two different ES cell lines) were compared with wild-type cousins of the same line. Ten corneas of wild-type and 14 corneas of Col8a1–/–/Col8a2–/– mice were removed, fixed in ice cold methanol for 10 min, and washed and permeabilized in 1% Triton-X100 for 10 min at room temperature. After blocking with 4% BSA in PBS, corneas were incubated with a 1:150 dilution of rabbit anti-ZO-1 antibody (Zymed Laboratories, San Francisco, CA, USA) for 2 h at room temperature. Specimens were washed, incubated with fluorescein-conjugated anti-rabbit IgG (DAKO) for 1 h, dilution 1:2000, and cut four times to allow them to flatten. Images were collected using 10x magnification and morphometrically analyzed using the computer program KS300.1.

Quantitative RT-PCR
For PCR amplifications of Col8a1, Col8a2, and ß-actin, first-strand cDNA was used with components of the SYBER Green Core PCR Reagent Kit (PE ABI, Foster City, CA, USA) on an iCycler iQ real-time PCR system (Bio-Rad). The cycling parameters were 50°C, for 3 min, 94°C for 10 min, followed by 50 cycles of 94°C for 30 s, 60°C for Col8a1, 65°C for Col8a2 for 30 s, and 72°C for 30 s. Three separate experiments were performed to quantitate the expression of each gene. In each experiment, three or more identical 20 µL PCR reactions of the gene of interest and the control gene ß-actin were run using the primers for ß-actin:sense: 5'-GTGGGCCGCTCTAGGCACCAA-3'; antisense: 5'-CTCTTTGATGTCACGCACGATTTC-3'; (Clontech), for Col8a1: sense: 5'-TCTGCCACCTCAAATCCCTCCTCA-3', antisense: 5'-TCTCCGCGCAAACTGGCTAACG-3', for Col8a2: 5'-GAGCGACGCGGAGTTCTG-3', antisense: 5'-CCCCCTGCATGGCGTCTGTG-3'. Relative expression levels of Col8a1 mRNA and Col8a2 mRNA in Col8a1–/–/Col8a2–/– organs were calculated separately for each of the three experiments. The relative expression values represent average values from three repeats of the experiments ± standard deviation. Threshold cycles were determined using the default threshold levels (10-fold standard deviation from cycle 2 to 10) and the average threshold cycles of the gene of interest were normalized for amplification of ß-actin, assuming an amplification efficiency of 2.0 in all reactions. The reaction products were analyzed on 3% Nusieve gels to verify the absence of nonspecific PCR products.

Statistical analysis
All values are presented as means ± standard deviation (SD). All experiments were repeated a minimum of three times. Statistical analyses were performed using SSPS version 10.1.3 for Windows and Microsoft Excel 97. Statistical significance between the wild-type and Col8a1–/–/Col8a2–/– values of Fig. 4B and Fig. 7 were tested using the nonparametric unpaired Mann-Whitney U test. A P value of <0.05 was considered significant. Data of Fig. 4A were analyzed by 1-way ANOVA with Tamhane post-tests. Level of significance was set at P < 0.05.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 4. A) Thickness of Descemet’s membrane. Col8a1–/–/Col8a2–/– mice showed a markedly thinned Descemet’s membrane of ~0.7 µm in electron micrographs. Descemet’s membrane of Col8a1–/– and Col8a2–/– mice had an average thickness of 1 µm. Col8a1+/–/Col8a2+/– mice had no differences in thickness of Descemet’s membrane compared with wild-type mice. B) Depth of the anterior chamber. The depth was distinctly increased in Col8a1–/–/Col8a2–/–, moderately increased in Col8a1–/– and normal in Col8a2–/– mice. C) Thickness of corneal stroma compared with wild-type mice. The corneal stroma was clearly thinned in Col8a1–/–/Col8a2–/–, moderately thinned in Col8a1–/– and normal in Col8a2–/– mice. No differences in the thickness of the epithelial layer were seen between the mutant and wild-type eyes.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 7. A) Results of 1 representative proliferation assay with mCECs after stimulation with 10% FCS, 25 ng/mL EGF, 25 ng/mL bFGF, 25 ng/mL NGF and control (0.1% FCS). [3H]thymidine incorporation was significantly less in Col8a1–/–/Col8a2–/– mCECs (square) compared with wild-type mCECs (black) stimulated with either FCS, EGF, bFGF, or NGF. B) Attachment assay after 24 h of attachment shows no difference between wild-type and Col8a1–/–/Col8a2–/– mCECs.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Generation of Col8a1 and Col8a2 null mice
The Col8a1 gene was targeted using a replacement construct that interrupted exon 2 with a cassette containing an internal ribosomal entry site (IRES), the gene for the enhanced green fluorescent protein (EGFP), and a neomycin gene, controlled by the PGK promoter (Fig. 1 A). Of 198 G418-resistant ES cell clones analyzed, two were found to have undergone homologous recombination at the Col8a1 locus; use of an internal probe demonstrated that a single copy of the targeting vector had been integrated into the genome (Fig. 1B-D ). Both stem cell lines were used to produce chimeras.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 1. A) Gene targeting at the Col8a1 locus. Exons are shown as black boxes. The Col8a1 gene was targeted by a replacement construct containing an 11 kb genomic DNA fragment of the mouse Col8a1 locus, with exon 2 interrupted by a cassette containing an internal ribosomal entry site (IRES), the gene for enhanced green fluorescent protein (EGFP), and a neomycin gene controlled by the PGK promoter (IGN). Banded boxes represent the internal and external probes. The external probe detected a 4 kb BglII fragment specific for the targeted allele (the cassette creates an additional BglII site) or a 9 kb fragment specific for the wild-type allele. Use of an internal probe revealed an 8 kb fragment, consistent with a single integration of the targeting vector. Numbers represent primers used for genotyping (primers 1 and 2: wild-type allele, 3 and 4: targeted allele, 3 and 5: long template PCR for detection of correctly targeted ES cell clones, E: EcoRI; Bg: BglII; B: BamHI; S: SacI) B) Southern hybridization using the external probe on mouse tail DNA. C) Southern hybridization using the internal probe on mouse tail DNA. D) Long template PCR of ES cell DNA revealed a positive PCR product at 2.3 kb. E) Northern blot analysis with a Col8a1-specific probe of RNA prepared from heads of newborn mice. Lane 1: Col8a2–/–; lane 2: WT; lane 3: Col8a1–/–; lane 4: Col8a1–/–/Col8a2–/–.

The Col8a2 gene was targeted with a positive/negative selection scheme using neomycin resistance for positive selection and thymidine kinase for negative selection (Fig. 2 A). Long template PCR and Southern blot analyses of DNA from 218 ES cell clones revealed four positive clones; an internal probe revealed a single integration (Fig. 2B-D ). One ES cell line was used to produce chimeras.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. A) Gene targeting at the Col8a2 locus. Exons are shown as black boxes. The Col8a2 gene was targeted with a positive/negative selection scheme using neomycin resistance for positive selection and thymidine kinase for negative selection. A neomycin resistance cassette (NEO) controlled by the PGK promoter was ligated into exon 1 of the Col8a2 gene of a 10 kb genomic DNA clone. Banded boxes represent the internal and external probes. The external probe hybridized with a 10 kb wild-type or a 12 kb targeted KpnI fragment. The internal probe revealed a 10 kb (wild-type) vs. a 6 kb targeted BamHI fragment (the cassette contains an additional BamHI site), consistent with a single integration site. Numbers represent primers used for genotyping (primer 1 and 2: wild-type allele, 3 and 2: targeted allele, 4 and 5: long template PCR for detection of correctly targeted ES cell clones). B) Southern hybridization using the external probe on mouse tail DNA. C) Southern hybridization using the internal probe on mouse tail DNA. D) Long template PCR of ES cell DNA revealed positive PCR products at 4.3 kb. E) Northern blot analysis with a Col8a1-specific probe of RNA prepared from heads of newborn mice. Lane 1: Col8a1–/–; lane 2: WT; lane 3: Col8a2–/–; lane 4: Col8a1–/–/Col8a2–/– mice.

Col8a1/Col8a2-deficient mice are viable, fertile, and show no major abnormalities
Homozygous mutant Col8a1 and Col8a2 mice were crossed to generate double heterozygous mice, which in turn were intercrossed to generate double null mutants. To confirm the disruption of both alleles of both genes, the absence of Col8a1 and Col8a2 transcripts was checked by Northern blot analysis. Total RNA of heads of newborn mice showed no detectable collagen VIII-specific transcripts (Fig. 1E , Fig. 2E ). Collagen type VIII-deficient mice appeared healthy, and no significant difference in growth rate was observed in control and collagen VIII-deficient mice. Collagen VIII-deficient mice were fertile and lactated normally, and no reduction in litter size was noted, indicating that neither fetal nor maternal collagen VIII is essential for embryonic development. Mice heterozygous for Col8a1, Col8a2, or for both null mutations were mated to check for Mendelian transmission with the following results. Of 325 Col8a1 mice, 80 (25%) offspring were wild-type, 158 (49%) heterozygotes, and 87 (27%) were homozygotes; of 395 Col8a2 mice, 107 (27%) were wild-type, 186 (47%) heterozygotes, and 102 (26%) were homozygotes. Of 422 Col8a1+/–/Col8a2+/– mice 27 were homozygotes, and 22 offspring were wild-type. Thus, the null mutations do not cause embryonic lethality, and mice completely lacking type VIII collagen are viable. Collagen VIII-deficient and control mice were aged up to 23 months and showed no significant difference in their life span.

All major internal organs, skeletal muscle, skin, salivary glands, and all major joints were dissected from 6-wk to 2-year-old mice and checked for macro- or microscopic changes, but no major anatomical abnormalities were found. Collectively, these results indicate that disruption of both collagen VIII genes does not affect fertility, development, or the life-span of mice in cages.

Lack of collagen VIII leads to an abnormal anterior chamber of the eye
Sections of eyes were made at the age of postnatal 2, 3, and 4 days, at 6, 7, 8, and 12 wk, 6 months, and 1 and 2 years. Macroscopic investigation revealed a keratoglobus-like depth of the anterior chamber as seen in Fig. 3 A, B. To confirm the increased depth of the anterior chamber, sections through the centers of 14 wild-type and 21 Col8a1–/–/Col8a2–/–eyes were made and the distances between the lens and the corneal endothelial cell layer were measured along the central axis of the eye (Fig. 3E, F , Fig. 4 B). Col8a1–/–/Col8a2–/–eyes revealed a mean depth of 392 ± 60 µm in contrast to wild-type eyes with 223 ± 49 µm (P<0.001). Differences were already seen at the age of 6 wk. This difference remained in aging mice and did not change with age. Sections of 10 Col8a1–/– eyes revealed a mean depth of 324 ± 48 µm, and in 8 sections of Col8a2–/– eyes a mean depth of 243 ± 65 µm was found (Fig. 4B ).



View larger version (58K):
[in this window]
[in a new window]
 
Figure 3. Keratoglobus-like extension of the anterior chamber in wild-type (A) and (B) in Col8a1–/–/Col8a2–/– mice. C) There is no corneal opacity in wild-type or Col8a1/Col8a2 mice (D) at the age of 2 years. E, F) Protrusion of the cornea in Col8a1–/–/Col8a2–/– mice (F) compared with wild-type (E) in H&E-stained sections. G) The stroma and Descemet’s membrane is thicker in wild-type (G) than in Col8a1–/–/Col8a2–/– mice (H). C: cornea; AC: anterior chamber; L: lens; S: stroma; arrowheads: Descemet’s membrane; EP: epithelial cell layer.

DM was markedly, and the corneal stroma slightly, thinner in collagen VIII null mice than in wild-type mice (Fig. 3G, H , Fig. 4A, C ). To rule out the possibility of errors due to oblique sections through the cornea, we measured the thickness of the corneal epithelial layer, since the measured thickness of all these layers (DM, corneal stroma, and epithelium) would be increased proportionally in nonperpendicular sections. Compared in this way, the thickness of the corneal stroma was reduced by 21.5 (±5.3)% in Col8a1–/–/Col8a2–/– eyes, by 12.3 (±4.3)% in Col8a1–/– eyes, and not reduced in Col8a2–/– eyes. The epithelium was the same thickness in wild-type and mutant mice (Fig. 4C ). No anterior synechias, guttata (wart-like expansions), or regions of corneal cloudiness were observed (Fig. 3C, D ). Endothelial cells did not continue onto the iris surface and Schlemm’s canal as seen in PPCD in humans, and the trabecular meshwork was visible and open.

Ultrastructural abnormalities in Col8a1–/–/Col8a2–/– corneas
Transmission electron microscopy revealed that DM in wild-type mice was 1.3 µm thick and showed two layers: a small anterior dense and a posterior more homogenous layer comparable to, but fainter, than the anterior banded and posterior nonbanded layers in human corneas (24) . In contrast to human corneas, there were abundant polymers of type VIII collagen within the posterior layer of wild-type mice with periodic banding at 100 nm intervals. In 2-year-old mice, DM showed an uneven appearance with focal thickening. This is different from human membranes, which increase uniformly in thickness with age (25) . Even wild-type mice showed attenuated endothelial cells at this age. This is probably due to age-related loss of endothelial cells and an impaired ability of corneal endothelial cells to proliferate. Col8a1–/–/Col8a2–/– mice showed a markedly thinner DM of 0.7(±0.1) µm in contrast to the wild-type membrane of 1.3 ± (0.2) µm already at the age of two months (Fig. 4A , Fig. 5 , P<0.001). The electron-dense anterior zone and any banding were lacking. To confirm that the difference in thickness was not due to a tissue processing artifact, we performed transmission electron microscopy of frozen sections and verified the results. Descemet’s membranes of Col8a1–/– or Col8a2–/– mice revealed a thickness of 1.0 (±0.1) µm in both cases (each P<0.001 compared with wild-type). A dense posterior layer was visible, but banded structures were only detectable in Col8a1–/– mice.



View larger version (104K):
[in this window]
[in a new window]
 
Figure 5. A) Electron micrograph (700x) of the cornea of a 2-month-old wild-type mouse. Descemet’s membrane (D) and the stroma (S) are markedly thinner in Col8a1–/–/Col8a2–/– mice (B). Picture inserts are higher magnifications (12,000x) of Descemet’s membrane and endothelial cells (EC). Note that the periodic banding (arrowheads) of Descemet’s membrane is missing in Col8a1–/–/Col8a2–/– mice (B).

Corneal endothelial cells were cuboidal and contained large and flattened nuclei in Col8a1–/–Col8a2–/– eyes. Endothelial cell borders interdigitated and overlapped normally. At the age of 2 years, there were no additional pathologic layers of material between endothelial cells and DM and no subepithelial fibrocellular tissue or subepithelial fluid as seen in corneal dystrophies in humans. There were no iridocorneal adhesions or lens abnormalities.

Decreased proliferation of corneal endothelial cells in Col8a1/Col8a2 null mice
To test the hypothesis that the thinning of the cornea may be due to a decrease in cell proliferation during corneal development, we isolated Col8a1–/–/Col8a2–/– and wild-type corneal endothelial cells (mCECs) and compared their ability to proliferate in response to various growth factors and 10% serum. The isolated corneal endothelial cells showed the expected paving-stone mosaic of polygonal cells (26) . mCECs of Col8a1–/–/Col8a2–/– mice were immunostained against EGFP (Fig. 6 A, B). Staining mCECs with antibodies against markers specific for vascular endothelial cells such as CD31/PECAM-1 or vWF was negative (data not shown). RT-PCR assays were performed on RNA of corneal endothelial cells of wild-type and Col8a1–/–/Col8a2–/– mice and renal tubular epithelial cells as described (20) . Wild-type mCECs were positive for Col8a1 RNA (Fig. 6G ), a corneal endothelial specific marker, and decorin RNA (Fig. 6H ), a marker for corneal endothelium and epithelium but not for stromal fibroblasts. Col8a1–/–/Col8a2–/– mCECs were positive for decorin RNA. All mCECs were negative for keratin14 RNA (Fig. 6I ), a marker for corneal epithelium. GAPDH was used as a control (Fig. 6J ). Immunostaining with antibodies against collagen VIII (Fig. 6C, D ) showed a punctate staining pattern in wild-type cells, consistent with previous descriptions of stained collagen VIII-synthesizing macrophages (27) , at least up to passage 6. Only faint background staining was visible with anti-collagen VIII in mCECs of Col8a1–/–/Col8a2–/– mice and in wild-type mCECs with isotype matched control IgG1.



View larger version (55K):
[in this window]
[in a new window]
 
Figure 6. Characterization of corneal endothelial cells (mCECs). A, B) Immunofluorescence staining with anti-EGFP antibody reveals no staining of wild-type (A) and strong staining of Col8a1–/–/Col8a2–/– mCECs (B). Immunofluorescence staining with anti-Collagen VIII antibody reveals punctate staining pattern in wild-type cells (C) and a faint background staining in Col8a1–/–/Col8a2–/– mCECs (D). E, F) The isolated corneal endothelial cells show the expected paving-stone mosaic of polygonal cells. GJ) RT-PCRs for Col8a1 (G), as a corneal endothelial specific marker, decorin (H), a marker for corneal endothelium and epithelium but not for stromal fibroblasts, keratin14 (I), a marker for corneal epithelium, and GAPDH as control (J), were performed on RNA of corneal endothelial cells of wild-type and Col8a1–/–/Col8a2–/– mice and renal tubule epithelial cells as a general epithelial cell control. Left lane: Molecular size markers. Lane 1: wild-type mCECs; lane 2: Col8a1–/–/Col8a2–/– mCECs; lane 3: renal tubule epithelial cells; lane 4: negative control.

Proliferation of cells lacking type VIII collagen and control cells was measured by [3H]thymidine incorporation (Fig. 7 A). In basal medium (0.1% FCS) lacking added growth factors, mCECs did not proliferate, and depletion of type VIII collagen had no effect on incorporation of thymidine (wild-type: 8927±863 cpm; Col8a1–/–/Col8a2–/–:10,768±1050 cpm). Incubation of mCECs with 10% serum for 16 h strongly induced proliferation of control and Col8a1–/–/Col8a2–/– mCECs, but [3H]thymidine incorporation was significantly less in Col8a1–/–/Col8a2–/– mCECs (42,237±5493 cpm vs. wild-type 57,666±11,823 cpm, P<0.05). To rule out the possibility that the decrease in counts for Col8a1–/–/Col8a2–/– mCECs was due to an impaired ability of these cells to attach, we performed attachment assays with cells that had been attached for 24 h. There was no significant difference in attachment between wild-type (OD 0.17±0.02) and Col8a1–/–/Col8a2–/– mCECs (OD 0.16±0.03) after 24 h (Fig. 7B ). After incubation with 25 ng/mL EGF, proliferation was reduced by 32% (17,963±2552 cpm vs. 12,181±1705 cpm; P<0.00001), with NGF by 37% (17,963±3140 cpm vs. 11,029±1617 cpm, P<0.00001), and with bFGF by 25% (21,526±2721 cpm vs. 16,168±1956 cpm; P<0.0001).

Corneal endothelial cells in Col8a1–/–/Col8a2–/– mice display polymegathism and polymorphism
One typical manifestation of corneal dystrophies is the appearance of large and polymorphic endothelial cells. These findings are most apparent by in vivo microscopy such as specular microscopy or by scanning electron microscopy (28) . To test whether polygonal or polymegal cells are present in Col8a1–/–/Col8a2–/– mice, we stained whole mounts of corneas with an antibody against ZO-1, a peripheral membrane protein associated with tight junctions between endothelial cells (29) . To describe accurately normal or diseased endothelial cells, three variables have been suggested (24) : 1 ) cell size, 2 ) the spread of cell size in terms of the standard deviation, and 3 ) heterogeneity of the endothelial population. The mean cell size was 936 ± 73 pixels for wild-type cells and 1095 ± 76 pixels for Col8a1–/–/Col8a2–/– cells (P<0.005, comparing Col8a1–/–/Col8a2–/– and 10 wild-type corneas). The histogram of cell size is skewed to the right for Col8a1–/–/Col8a2–/– corneas because of the presence of more large cells (Fig. 8 ).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 8. The histograms of individual cell size show the relative amounts of small and large cells. A) Histogram from wild-type corneas of mice between 4 and 8 months of age. B) The emergence of larger cells in Col8a1–/–/Col8a2–/–corneas of the same age skews the curve toward the right. The bar represents the mean cell size of wild-type cells (936±72.8 pixels); the mean of Col8a1–/–/Col8a2–/– corneas is 1095 ± 75.7 pixels. The difference in cell size is statistically significant (P<0.005).

Expression of {alpha}1(VIII) collagen in the developing and postnatal eye
To gain further insight into the expression pattern of {alpha}1 (VIII) collagen, we had inserted the EGFP gene into the Col8a1 replacement vector so that EGFP would be expressed under the control of the Col8a1 promoter in the targeted Col8a1 null allele (see Materials and Methods). Since the expression of EGFP was insufficient for detection by direct fluorescence microscopy, we enhanced the fluorescence using immunofluorescence detection with an anti-EGFP antibody (Fig. 9 ). Wild-type mice and nonimmune rabbit serum were used as negative controls (Fig. 9D, G, H ). We observed strong staining in the condensation of mesenchymal cells forming the future corneal stroma and endothelium at E14.5 (Fig. 9A, B ). During E15.5 (Fig. 9C, D ) to E17.5 (Fig. 9E, F ), staining remained in most posteriorly condensed mesenchyme, seen as a layer of mesothelium (corneal endothelium) and in more regularly arranged future stromal cells. Stromal and endothelial staining was seen until the first postnatal day (Fig. 9G, H ). Additional staining was detected in the pigmented epithelium underneath the developing retina and in the pigment epithelium of the ciliary processes at the growing edge of the optic cup (Fig. 9B, I ) (30) . In the adult cornea, strong staining was evident in corneal endothelial cells (Fig. 9K ) and in the trabecular meshwork (Fig. 9L ); no staining was apparent in the stroma or the corneal epithelial cell layer.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 9. Strong staining for EGFP seen at E14.5 (A, B) in a condensation of mesenchymal cells forming the future stroma and endothelium of the cornea. E15.5 (C, D) to E17.5 (E, F): staining remained in the most posteriorly condensed mesenchyme and in more regularly arranged future stromal cells. Stromal and endothelial staining remained until the first postnatal day (G, F). Further staining was seen at all stages in the pigment epithelium (I) underneath the growing retina and in the pigment epithelium of the ciliary process at the growing edge of the optic cup. In the adult cornea, strong staining was evident in corneal endothelial cells (K) and in the trabecular meshwork (L) whereas no staining was apparent in the stroma or the corneal epithelial cell layer. (K, L) A nonimmune rabbit serum was used as control (J). PE: pigment epithelium, R: retina, L: lens, C: cornea, LF: lid fold, I: iris, EN: endothelium, EP: epithelium, S: stroma, CI: ciliary body, TR: trabecular meshwork.

Up-regulation of Col8a1 mRNA in the aorta of Col8a2–/– mice
Functional redundancy within protein families has been proposed for several mice that show only minor phenotypes following targeted inactivation of genes encoding different extracellular matrix proteins (15 , 31 32 33) . This raises the question of whether the targeted deletion of Col8a1 gene function might have an effect on the transcriptional activity of the Col8a2 gene and vice versa. Col8a1 and/or Col8a2 are expressed in the eye, aorta, kidney, brain, heart, muscle, and lung (2 , 3 , 34 35 36) . Real-time RT-PCR analyses of RNA prepared from adult Col8a1–/– mice showed a decrease of Col8a2 mRNA in almost all tissues (eye: 31±0.5%, spleen: 54±0.9%, aorta: 47±1.5%, kidney: 42±1.1%, brain: 69±2.2%, lung: 51±1.8%, liver: 50±0.6%, muscle: 55±3.6%, intestine: 63±4.8%, and testis: 90±6.9%), except for the heart (103±2.6%) (Fig. 10 A). In contrast, Col8a1 mRNA in Col8a2–/– mice decreased in the eye (41±1.2%), kidney (57±1.5%), lung (39±1.4%) muscle (72±2.2%), liver (49±1.1%), spleen (19±0.9%) and testis (75±3.3%), but there was a strong increase of Col8a1 mRNA in aorta (228±3.6%) and a slight increase in the heart (127±3.9%) (Fig. 10B ). Transcript levels did not seem to be altered in the brain (110±1.1%) and intestine (111±2.4%).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 10. Real-time RT-PCR analyses of RNA prepared from adult tissues of Col8a1–/– mice showed a decrease of Col8a2 mRNA in almost all tissues tested except for the mRNA in the heart, which increased slightly. Col8a1 mRNA decreased in the eye, kidney, lung and muscle of Col8a2–/– mice, but there was a strong increase of Col8a1 mRNA in aorta and a slight increase in the heart. Transcript levels seemed to be constant in the brain.

These findings suggest that Col8a1 mRNA is up-regulated in the aorta of Col8a2–/–mice in response to the loss of Col8a2, but Col8a1 does not compensate for Col8a2 in other tissues. In fact, Col8a1 expression is reduced in most tissues of Col8a2–/– mice; the same is true for Col8a2 expression in Col8a1–/– mice.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The anterior segment of the vertebrate eye consists of highly organized and specialized tissues, which combine optical transparency and refractive power with mechanical flexibility. Neural crest-derived cells of the periocular mesenchyme, a mesodermal layer surrounding the early optic cup, contribute extensively to the formation of the anterior segment. Between embryonic day 12 and 15 (E12–E15) in mice, these cells proliferate and migrate in one wave underneath the corneal epithelium. They differentiate and form the corneal stroma, corneal endothelium, anterior chamber angle, and the anterior iris (37 38 39) . This developmental process is regulated by a complex and incompletely understood series of interactions between the mesenchymal cells, cytokines and the extracellular matrix (ECM). Overexpression of TGF{alpha} and EGF or TGFß1 in the ocular lens or lack of TGFß2 leads to multiple anterior segment defects in mice (39 , 40) . Lack of {alpha}1(I) collagen leads to abnormally thin corneas with disorganized collagen fibrils (41) , and mice deficient in lumican exhibit deregulated assembly of collagen fibrils in the cornea (42) .

The data presented here demonstrate that mice with inactivated Col8a1 and Col8a2 genes manifest a dysgenesis of the anterior segment of the eye with a globoid, keratoglobus-like protrusion of the anterior chamber: the depth of the anterior chamber is increased and the corneal stroma is thin. A thin Descemet’s membrane separates the corneal stroma from the corneal endothelial cells, which are enlarged and decreased in number.

The globoid, keratoglobus-like protusion of the anterior chamber with a thin corneal stroma suggests that expression of type VIII collagen during corneal development is important for establishing the appropriate number of stromal fibroblastic layers. We suggest that the reduced number of these layers (see Fig. 5 ) in collagen VIII null mice may be due to a reduced ability of periocular mesenchymal cells to proliferate and/or migrate in the absence of collagen VIII. Collagen VIII is expressed by a number of rapidly proliferating cells such as different tumor cells and endothelial cells during angio- and vasculogenesis and throughout the development of hemangiomas (34 , 43 44 45 46 47 48 49 50 51 52) . Pericellular collagen VIII may therefore function during development to help maintain cells in a proliferative state. Consistent with this hypothesis is the finding that collagen VIII-deficient corneal endothelial cells derived from collagen VIII-expressing periocular mesenchyme show reduced proliferation in vitro (compared with wild-type cells) and are in vivo reduced in number and therefore enlarged (Figs. 7 , 8) . Collagen VIII has also been suggested to act as a chemotactic factor for mesenchymal cells such as smooth muscle cells and to provide a substrate for enhanced migration (50 , 53) . It is possible, therefore, that the presence of collagen VIII during migration of periocular mesenchymal cells into the developing cornea (see Fig. 9 ) provides a migratory substrate for the cells. A reduced migration of cells into the developing cornea could conceivably result in a reduced number of layers of corneal fibroblasts and collagen layers in the collagen VIII null eyes. Obviously, a reduction in proliferation and migration could contribute to the thinning of the cornea seen in knockout eyes.

Mutations in VSX1, a member of the Vsx group of vertebrate paired-like homeodomain transcription factors (54) , have been reported in patients with keratoconus or PPCD (55) . One of the mutations resulting in keratoconus (R166W) alters the homeodomain and impairs binding of VSX1 to DNA. Other sequence changes are missense mutations close to the homeodomain; these could also affect DNA binding. Since mice lacking collagen VIII display keratoglobus, a condition that in humans resembles keratoconus with a generalized globoid protrusion of a clear, diffusely thin cornea and a deep anterior chamber, it is tempting to speculate that collagen VIII is downstream of VSX1 during the development of the cornea.

Thinning of the cornea is also seen in mutations affecting the synthesis of other matrix components of the cornea. For example, mice deficient for the small proteoglycans lumican or keratocan have thin corneas, but show a decreased iridocorneal angle, unlike the collagen VIII-deficient mice in which this angle is increased (5 , 42) . Furthermore, mutations in keratocan in humans cause the more severe, recessively inherited form of cornea plana (56) . Thus, it is likely that keratoglobus in the collagen VIII-deficient mice is caused by a combination of corneal thinning and the absence of collagen VIII from the Descemet’s membrane, and not by corneal thinning alone.

The posterior corneal phenotype of Descemet’s membrane thinning and reduced number of endothelial cells in collagen VIII knockout mice is different from what is seen in patients with PPCD and FECD, both conditions for which mutations in COL8A2 have been reported (16) . In FECD, a primary degenerative disease that affects the corneal endothelium, Descemet’s membrane is markedly thickened by additional abnormal layers of material and wart-like outgrowths (57) . The basic endothelial cell abnormality in FECD is not known, but altered synthesis and/or assembly of extracellular matrix components are suspected (58) . In PPCD, endothelial cells often retain their ability to divide, become multilayered and extend onto the trabecular meshwork (59) . Localized or diffuse thickenings of Descemet’s membrane with deposits of abnormal collagenous material and flattened, enlarged and widely spaced endothelial cells are also a common finding (17) . In normal eyes, the anterior zone of banded fibrils in the Descemet’s membrane reaches its maximal thickness by the time of birth and appears to remain unchanged thereafter. However, in corneal endotheliopathies secretion of type VIII collagen appears to be resumed, resulting in an abnormal accumulation of wide-spaced collagen in a posterior collagenous layer subjacent to the endothelial cells (15) . Such alterations have not been observed in collagen VIII KO mice, even in old mice. The reduced number and abnormal size distribution of corneal endothelial cells in the mice is reminiscent of the reduced endothelial cell number reported for familial cases of PPCD (30) . However, the cellular mechanisms are likely quite different. In the mice, the reduced number of corneal endothelial cells is most likely the result of a decrease in proliferation of the endothelial cells during embryonic development, whereas excessive apoptosis has been proposed as a mechanism in the case of FECD (60 , 61) .

Thus, the pathogenetic mechanisms are probably quite different between mice with abnormalities caused by lack of collagen VIII and corneal endotheliopathies, even when some aspects of the phenotypic outcome look similar. The most likely explanation for these differences is that the reported mutations in COL8A2 in the human corneal dystrophies cause abnormal collagen VIII to be deposited in the Descemet’s membrane, in close proximity to the endothelial cells. The presence of this abnormal collagen VIII may result in increased endothelial cell proliferation and/or increased apoptosis. In contrast, complete lack of collagen VIII results in decreased endothelial proliferation and a thin Descemet’s membrane without the anterior banded collagen VIII-containing zone. The thinning of the Descemet’s membrane in the Col8a1–/–/Col8a2–/– double mutant was about twice the thinning seen in the single mutants (Fig. 4A ). In addition, banded structures within the Descemet’s membrane were completely absent in the Col8a2–/– mutant eyes. This suggests that {alpha}1(VIII) and {alpha}2(VIII) homotrimeric molecules may be localized within different regions of Descemet’s membrane and that the banded structures depend primarily on the presence of {alpha}2(VIII) homotrimers. Finally, our data clearly demonstrate that while collagen VIII is a major component of the anterior portion of Descemet’s membrane, collagen VIII molecules are not essential for the formation of this membrane during eye development.

The differential effects on transcript levels of the expressed collagen VIII polypeptide in mice homozygous for targeted alleles of Col8a1 or Col8a2 are consistent with the conclusion that collagen VIII molecules are homotrimers of {alpha}1(VIII) or {alpha}2(VIII) chains and that different tissues/cells regulate the proportion between the two types of proteins in different ways. In most tissues, the absence of one type of collagen VIII molecule results in a reduced expression level of the other, but in the aorta, the loss of {alpha}2(VIII) collagen results in a 2-fold increase in {alpha}1(VIII) mRNA levels. In contrast, the lack of {alpha}1(VIII) collagen leads to a reduced level of {alpha}2(VIII) mRNA, even in the aorta. The basis for this striking difference between the two collagen VIII proteins in the aorta is not clear, but one possibility that needs to be considered in future studies is that lack of {alpha}2(VIII) collagen results in up-regulation of {alpha}1(VIII) collagen in smooth muscle cells in the aortic wall. Collagen VIII is dramatically up-regulated in smooth muscle cells after damage to arterial endothelium and intima (53 , 62 , 63) . It is therefore possible that absence of {alpha}2(VIII) collagen in aorta generates "microdamage" and a "collagen VIII response" by smooth muscle cells. Detailed future studies comparing the structures and functional properties of the aortas of the two single collagen VIII null mice described here should provide insights into this and other possibilities.


   ACKNOWLEDGMENTS
 
We would like to acknowledge Oliver Steinmetz for help with statistical analyses; James A. Grunkemeyer and Daniel Rieger for helpful discussions; Maria Ericsson, Ursula Kneissler, and Udo Helmchen for expert assistance with electron microscopy. The technical assistance of Sofiya Plotkina was greatly appreciated. The work was supported by NIH grants AR36819 and AR36820 (to B.R.O).


   FOOTNOTES
 
1 Present address: Department of Medicine, University of Hamburg, D-20246 Hamburg, Germany.

2 Present address: Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.

Received for publication October 7, 2004. Accepted for publication March 30, 2005.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Benya, P. D. (1980) EC collagen: biosynthesis by corneal endothelial cells and separation from type IV without pepsin treatment or denaturation. Ren. Physiol. 3,30-35[Medline]
  2. Muragaki, Y., Shiota, C., Inoue, M., Ooshima, A., Olsen, B. R., Ninomiya, Y. (1992) alpha 1(VIII)-collagen gene transcripts encode a short-chain collagen polypeptide and are expressed by various epithelial, endothelial and mesenchymal cells in newborn mouse tissues. Eur. J. Biochem. 207,895-902[Medline]
  3. Kittelberger, R., Davis, P. F., Flynn, D. W., Greenhill, N. S. (1990) Distribution of type VIII collagen in tissues: an immunohistochemical study. Connect. Tissue Res. 24,303-318[Medline]
  4. Sage, H., Pritzl, P., Bornstein, P. (1982) Endothelial cells secrete a novel collagen type in vitro independently of prolyl hydroxylation. Coll. Relat. Res. 2,465-479[Medline]
  5. Liu, C. Y., Birk, D. E., Hassell, J. R., Kane, B., Kao, W. W. (2003) Keratocan-deficient mice display alterations in corneal structure. J. Biol. Chem. 28,28
  6. Yamaguchi, N., Benya, P. D., van der Rest, M., Ninomiya, Y. (1989) The cloning and sequencing of alpha 1(VIII) collagen cDNAs demonstrate that type VIII collagen is a short chain collagen and contains triple-helical and carboxyl-terminal non-triple-helical domains similar to those of type X collagen. J. Biol. Chem. 264,16022-16029[Abstract/Free Full Text]
  7. Muragaki, Y., Jacenko, O., Apte, S., Mattei, M. G., Ninomiya, Y., Olsen, B. R. (1991) The alpha 2(VIII) collagen gene. A novel member of the short chain collagen family located on the human chromosome 1. J. Biol. Chem. 266,7721-7727[Abstract/Free Full Text]
  8. Muragaki, Y., Mattei, M. G., Yamaguchi, N., Olsen, B. R., Ninomiya, Y. (1991) The complete primary structure of the human alpha 1 (VIII) chain and assignment of its gene (COL8A1) to chromosome 3. Eur. J. Biochem. 197,615-622[Medline]
  9. Yamaguchi, N., Mayne, R., Ninomiya, Y. (1991) The alpha 1 (VIII) collagen gene is homologous to the alpha 1 (X) collagen gene and contains a large exon encoding the entire triple helical and carboxyl-terminal non-triple helical domains of the alpha 1 (VIII) polypeptide. J. Biol. Chem. 266,4508-4513[Abstract/Free Full Text]
  10. Illidge, C., Kielty, C., Shuttleworth, A. (1998) The alpha1(VIII) and alpha2(VIII) chains of type VIII collagen can form stable homotrimeric molecules. J. Biol. Chem. 273,22091-22095[Abstract/Free Full Text]
  11. Greenhill, N. S., Ruger, B. M., Hasan, Q., Davis, P. F. (2000) The alpha1(VIII) and alpha2(VIII) collagen chains form two distinct homotrimeric proteins in vivo. Matrix Biol. 19,19-28[CrossRef][Medline]
  12. Sawada, H., Konomi, H., Hirosawa, K. (1990) Characterization of the collagen in the hexagonal lattice of Descemet’s membrane: its relation to type VIII collagen. J. Cell Biol. 110,219-227[Abstract/Free Full Text]
  13. Jakus, M. A. (1956) Studies on the cornea. II. The fine structure of Descemet’s membrane. J. Biophys. Biochem. Cytol. 2(Suppl.),243-252
  14. Levy, S. G., McCartney, A. C., Sawada, H., Dopping-Hepenstal, P. J., Alexander, R. A., Moss, J. (1995) Descemet’s membrane in the iridocorneal-endothelial syndrome: morphology and composition. Exp. Eye Res. 61,323-333[CrossRef][Medline]
  15. Murphy, C., Alvarado, J., Juster, R. (1984) Prenatal and postnatal growth of the human Descemet’s membrane. Invest. Ophthalmol. Vis. Sci. 25,1402-1415[Abstract/Free Full Text]
  16. Biswas, S., Munier, F. L., Yardley, J., Hart-Holden, N., Perveen, R., Cousin, P., Sutphin, J. E., Noble, B., Batterbury, M., Kielty, C., et al (2001) Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum. Mol. Genet. 10,2415-2423[Abstract/Free Full Text]
  17. Grupcheva, C. N., Chew, G. S., Edwards, M., Craig, J. P., McGhee, C. N. (2001) Imaging posterior polymorphous corneal dystrophy by in vivo confocal microscopy. Clin. Exp. Ophthalmol. 29,256-259[CrossRef][Medline]
  18. Li, E., Bestor, T. H., Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69,915-926[CrossRef][Medline]
  19. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., Berns, A. (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19,4293[Free Full Text]
  20. Chen, K. H., Harris, D. L., Joyce, N. C. (1999) TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 40,2513-2519[Abstract/Free Full Text]
  21. Gospodarowicz, D., Mescher, A. L., Birdwell, C. R. (1977) Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors. Exp. Eye Res. 25,75-89[CrossRef][Medline]
  22. Savion, N., Vlodavsky, I., Gospodarowicz, D. (1981) Nuclear accumulation of epidermal growth factor in cultured bovine corneal endothelial and granulosa cells. J. Biol. Chem. 256,1149-1154[Abstract/Free Full Text]
  23. Fabricant, R. N., Alpar, A. J., Centifanto, Y. M., Kaufman, H. E. (1981) Epidermal growth factor receptors on corneal endothelium. Arch. Ophthalmol. 99,305-308[Abstract/Free Full Text]
  24. Waring, G. O., III, Bourne, W. M., Edelhauser, H. F., Kenyon, K. R. (1982) The corneal endothelium. Normal and pathologic structure and function. Ophthalmology 89,531-590[Medline]
  25. Johnson, D. H., Bourne, W. M., Campbell, R. J. (1982) The ultrastructure of Descemet’s membrane. I. Changes with age in normal corneas. Arch. Ophthalmol. 100,1942-1947[Abstract/Free Full Text]
  26. Rao, G. N., Lohman, L. E., Aquavella, J. V. (1982) Cell size-shape relationships in corneal endothelium. Invest. Ophthalmol. Vis. Sci. 22,271-274[Abstract/Free Full Text]
  27. Weitkamp, B., Cullen, P., Plenz, G., Robenek, H., Rauterberg, J. (1999) Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J. 13,1445-1457[Abstract/Free Full Text]
  28. Henriquez, A. S., Kenyon, K. R., Dohlman, C. H., Boruchoff, S. A., Forstot, S. L., Meyer, R. F., Hanninen, L. A. (1984) Morphologic characteristics of posterior polymorphous dystrophy. A study of nine corneas and review of the literature. Surv. Ophthalmol. 29,139-147[CrossRef][Medline]
  29. Chen, K. H., Azar, D., Joyce, N. C. (2001) Transplantation of adult human corneal endothelium ex vivo: a morphologic study. Cornea 20,731-737[CrossRef][Medline]
  30. Pearce, W. G., Tripathi, R. C., Morgan, G. (1969) Congenital endothelial corneal dystrophy. Clinical, pathological, and genetic study. Br. J. Ophthalmol. 53,577-591[Free Full Text]
  31. Forsberg, E., Hirsch, E., Frohlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S., Fassler, R. (1996) Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. USA 93,6594-6599[Abstract/Free Full Text]
  32. Aszodi, A., Pfeifer, A., Wendel, M., Hiripi, L., Fassler, R. (1998) Mouse models for extracellular matrix diseases. J. Mol. Med. 76,238-252[CrossRef][Medline]
  33. Jones, P. L., Jones, F. S. (2000) Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 19,581-596[CrossRef][Medline]
  34. Paulus, W., Sage, E. H., Liszka, U., Iruela-Arispe, M. L., Jellinger, K. (1991) Increased levels of type VIII collagen in human brain tumours compared to normal brain tissue and non-neoplastic cerebral disorders. Br. J. Cancer 63,367-371[Medline]
  35. Paulus, W., Sage, E. H., Jellinger, K., Roggendorf, W. (1992) Type VIII collagen in the normal and diseased human brain. Acta Histochem. Suppl. 42,195-199[Medline]
  36. Iruela-Arispe, M. L., Sage, E. H. (1991) Expression of type VIII collagen during morphogenesis of the chicken and mouse heart. Dev. Biol. 144,107-118[CrossRef][Medline]
  37. Flugel-Koch, C., Ohlmann, A., Piatigorsky, J., Tamm, E. R. (2002) Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice. Dev. Dyn. 225,111-125[CrossRef][Medline]
  38. Hay, E. D. (1979) Development of the vertebrate cornea. Int. Rev. Cytol. 63,263-322[Medline]
  39. Reneker, L. W., Silversides, D. W., Xu, L., Overbeek, P. A. (2000) Formation of corneal endothelium is essential for anterior segment development—a transgenic mouse model of anterior segment dysgenesis. Development 127,533-542[Abstract]
  40. Saika, S., Liu, C. Y., Azhar, M., Sanford, L. P., Doetschman, T., Gendron, R. L., Kao, C. W., Kao, W. W. (2001) TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev. Biol. 240,419-432[CrossRef][Medline]
  41. Bard, J. B., Bansal, M. K., Ross, A. S. (1988) The extracellular matrix of the developing cornea: diversity, deposition and function. Development 103(Suppl.),195-205
  42. Chakravarti, S., Magnuson, T., Lass, J. H., Jepsen, K. J., LaMantia, C., Carroll, H. (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 141,1277-1286[Abstract/Free Full Text]
  43. Alitalo, K., Bornstein, P., Vaheri, A., Sage, H. (1983) Biosynthesis of an unusual collagen type by human astrocytoma cells in vitro. J. Biol. Chem. 258,2653-2661[Free Full Text]
  44. Tan, S. T., Velickovic, M., Ruger, B. M., Davis, P. F. (2000) Cellular and extracellular markers of hemangioma. Plast. Reconstr. Surg. 106,529-538[CrossRef][Medline]
  45. Xu, R., Yao, Z. Y., Xin, L., Zhang, Q., Li, T. P., Gan, R. B. (2001) NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem. Biophys. Res. Commun. 289,264-268[CrossRef][Medline]
  46. Iruela-Arispe, M. L., Hasselaar, P., Sage, H. (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64,174-186[Medline]
  47. MacBeath, J. R., Kielty, C. M., Shuttleworth, C. A. (1996) Type VIII collagen is a product of vascular smooth-muscle cells in development and disease. Biochem. J. 319,993-998
  48. Bendeck, M. P., Regenass, S., Tom, W. D., Giachelli, C. M., Schwartz, S. M., Hart, C., Reidy, M. A. (1996) Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB–stimulated rat carotid arteries. Circ. Res. 79,524-531[Abstract/Free Full Text]
  49. Chakravarti, S. (2001) The cornea through the eyes of knockout mice. Exp. Eye Res. 73,411-419[CrossRef][Medline]
  50. Hou, G., Mulholland, D., Gronska, M. A., Bendeck, M. P. (2000) Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am. J. Pathol. 156,467-476[Abstract/Free Full Text]
  51. Tan, S. T., Wallis, R. A., He, Y., Davis, P. F. (2004) Mast cells and hemangioma. Plast. Reconstr. Surg. 113,999-1011[CrossRef][Medline]
  52. Hirano, S., Yonezawa, T., Hasegawa, H., Hattori, S., Greenhill, N. S., Davis, P. F., Sage, E. H., Ninomiya, Y. (2004) Astrocytes express type VIII collagen during the repair process of brain cold injury. Biochem. Biophys. Res. Commun. 317,437-443[CrossRef][Medline]
  53. Sibinga, N. E., Foster, L. C., Hsieh, C. M., Perrella, M. A., Lee, W. S., Endege, W. O., Sage, E. H., Lee, M. E., Haber, E. (1997) Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ. Res. 80,532-541[Abstract/Free Full Text]
  54. Semina, E. V., Mintz-Hittner, H. A., Murray, J. C. (2000) Isolation and characterization of a novel human paired-like homeodomain-containing transcription factor gene, VSX1, expressed in ocular tissues. Genomics 63,289-293[CrossRef][Medline]
  55. Heon, E., Greenberg, A., Kopp, K. K., Rootman, D., Vincent, A. L., Billingsley, G., Priston, M., Dorval, K. M., Chow, R. L., McInnes, R. R., et al (2002) VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum. Mol. Genet. 11,1029-1036[Abstract/Free Full Text]
  56. Pellegata, N. S., Dieguez-Lucena, J. L., Joensuu, T., Lau, S., Montgomery, K. T., Krahe, R., Kivela, T., Kucherlapati, R., Forsius, H., de la Chapelle, A. (2000) Mutations in KERA, encoding keratocan, cause cornea plana. Nat. Genet. 25,91-95[CrossRef][Medline]
  57. Kenney, M. C., Labermeier, U., Hinds, D., Waring, G. O., III (1984) Characterization of the Descemet’s membrane/posterior collagenous layer isolated from Fuchs’ endothelial dystrophy corneas. Exp. Eye Res. 39,267-277[CrossRef][Medline]
  58. Levy, S. G., Moss, J., Noble, B. A., McCartney, A. C. (1996) Early-onset posterior polymorphous dystrophy. Arch. Ophthalmol. 114,1265-1268[Abstract/Free Full Text]
  59. Heon, E., Mathers, W. D., Alward, W. L., Weisenthal, R. W., Sunden, S. L., Fishbaugh, J. A., Taylor, C. M., Krachmer, J. H., Sheffield, V. C., Stone, E. M. (1995) Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum. Mol. Genet. 4,485-488[Abstract/Free Full Text]
  60. Gottsch, J. D., Bowers, A. L., Margulies, E. H., Seitzman, G. D., Kim, S. W., Saha, S., Jun, A. S., Stark, W. J., Liu, S. H. (2003) Serial analysis of gene expression in the corneal endothelium of Fuchs’ dystrophy. Invest. Ophthalmol. Vis. Sci. 44,594-599[Abstract/Free Full Text]
  61. Li, Q. J., Ashraf, M. F., Shen, D. F., Green, W. R., Stark, W. J., Chan, C. C., O’Brien, T. P. (2001) The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch. Ophthalmol. 119,1597-1604[Abstract/Free Full Text]
  62. Bendeck, M. P., Regenass, S., Tom, W. D., Giachelli, C. M., Schwartz, S. M., Hart, C., Reidy, M. A. (1996) Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB–stimulated rat carotid arteries. Circ. Res. 79,524-531
  63. Sinha, S., Kielty, C. M., Heagerty, A. M., Canfield, A. E., Shuttleworth, C. A. (2001) Up-regulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis. Int. J. Exp. Pathol. 82,295-302[CrossRef][Medline]



This article has been cited by other articles:


Home page
DiabetesHome page
U. Hopfer, H. Hopfer, C. Meyer-Schwesinger, I. Loeffler, N. Fukai, B. R. Olsen, R. A.K. Stahl, and G. Wolf
Lack of Type VIII Collagen in Mice Ameliorates Diabetic Nephropathy
Diabetes, July 1, 2009; 58(7): 1672 - 1681.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Kabosova, D. T. Azar, G. A. Bannikov, K. P. Campbell, M. Durbeej, R. F. Ghohestani, J. C. R. Jones, M. C. Kenney, M. Koch, Y. Ninomiya, et al.
Compositional Differences between Infant and Adult Human Corneal Basement Membranes
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4989 - 4999.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
A. J. Aldave and B. Sonmez
Elucidating the Molecular Genetic Basis of the Corneal Dystrophies: Are We There Yet?
Arch Ophthalmol, February 1, 2007; 125(2): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Aldave, S. A. Rayner, A. K. Salem, G. L. Yoo, B. T. Kim, M. Saeedian, B. Sonmez, and V. S. Yellore
No Pathogenic Mutations Identified in the COL8A1 and COL8A2 Genes in Familial Fuchs Corneal Dystrophy.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3787 - 3790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Hopfer, H. Hopfer, K. Jablonski, R. A. K. Stahl, and G. Wolf
The Novel WD-repeat Protein Morg1 Acts as a Molecular Scaffold for Hypoxia-inducible Factor Prolyl Hydroxylase 3 (PHD3)
J. Biol. Chem., March 31, 2006; 281(13): 8645 - 8655.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Adiguzel, G. Hou, D. Mulholland, U. Hopfer, N. Fukai, B. Olsen, and M. Bendeck
Migration and Growth Are Attenuated in Vascular Smooth Muscle Cells With Type VIII Collagen-Null Alleles
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 56 - 61.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hopfer, U.
Right arrow Articles by Olsen, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hopfer, U.
Right arrow Articles by Olsen, B. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS